Company news

ProQR Therapeutics N.V. news in 2026

ProQR Therapeutics N.V.'s news releases, calls and decks from 2026, newest first.

View company

ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming Conferences

October 28, 2026

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

September 23, 2026

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

September 9, 2026

ProQR to Participate in Upcoming Investor Conferences in September 2026

September 2, 2026

ProQR Announces Second Quarter 2026 Operating and Financial Results

August 13, 2026

ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement

June 25, 2026

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

June 25, 2026

ProQR Announces First Quarter 2026 Operating and Financial Results

May 12, 2026

ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform

May 11, 2026

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

May 4, 2026

ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors

April 30, 2026

ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board

April 7, 2026

ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026

March 25, 2026

ProQR Announces Year End 2025 Operating and Financial Results

March 12, 2026

ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference

March 3, 2026

ProQR Announces Planned Changes to Board Composition

February 9, 2026

ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook

January 8, 2026

Decks in 2026